Candida infection testing market overview (2026–2030)
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Candida Infection Testing Market Expected To Reach Based On Its 2026 Value?
The candida infection testing market size has shown significant development in recent times. It is anticipated to increase from $16.72 billion in 2025 to $17.8 billion in 2026, registering a compound annual growth rate (CAGR) of 6.4%. The expansion observed in prior periods is attributable to the increasing occurrence of fungal infections, a growing number of immunocompromised individuals, the broadening of diagnostic services in hospitals, the uptake of culture-based fungal testing, and heightened awareness regarding antifungal resistance.
The candida infection testing market is projected to experience substantial expansion over the upcoming years. Its valuation is set to reach $22.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This anticipated growth throughout the forecast period stems from several factors, including the escalating demand for swift fungal diagnostic solutions, the increasing embrace of molecular and microbiome testing methodologies, the broadening scope of point-of-care fungal testing, the rising tide of investments in infectious disease diagnostics, and an intensified focus on customized antifungal therapeutic approaches. Key trends characterizing this period encompass the growing acceptance of molecular methods for candida detection, a surge in the utilization of rapid NAAT-based testing, the increasing incorporation of microbiome analysis, the expansion of fungal diagnostic services within hospitals, and a heightened emphasis on identifying fungal infections at an early stage.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report
Which Major Drivers Are Influencing The Expansion Of The Candida Infection Testing Market?
A rising incidence of yeast infections is expected to propel the growth of the candida infection testing market going forward. Yeast infections are fungal conditions caused by the excessive proliferation of candida, commonly affecting areas such as the mouth, genitals, and skin, often resulting in itching, redness, and discomfort. These infections are primarily caused by an overgrowth of the fungus candida, often due to imbalances in the body’s natural bacteria, weakened immune systems, or hormonal changes. Candida infection testing is utilized in yeast infections to accurately diagnose the presence of candida overgrowth, assisting healthcare providers in confirming the infection and guiding appropriate treatment. For instance, in May 2025, according to the UK Health Security Agency, a UK-based government public health agency, bloodstream infections caused by yeast in England rose by 4% in 2024 compared with 2023, increasing from 2,170 to 2,247 reports, and the rate increased from 3.8 to 3.9 per 100,000 population over the same period. Therefore, the increasing occurrence of yeast infections will drive the growth of the candida infection testing market.
How Are Segments Identified Within The Candida Infection Testing Market Segment Framework?
The candida infection testing market covered in this report is segmented –
1) By Type: Invasive Candidiasis, Candidemia
2) By Test Type: Vaginal pH Test, Nucleic Acid Amplification Testing (NAAT), Microbiome Test
3) By Application: Hospital, Laboratory
Subsegments:
1) By Invasive Candidiasis: Tissue Biopsy Testing, Urine Culture Testing, Blood Culture Testing
2) By Candidemia: Blood Tests, Serological Testing, Molecular Testing
Which Trends Are Shaping The Candida Infection Testing Market?
Leading companies active in the candida infection testing market are concentrating on developing technologically advanced solutions, such as fully automated PCR rapid tests for candida detection, to heighten diagnostic accuracy and better patient outcomes. A fully automated PCR rapid test for detecting candida is a high-tech diagnostic tool that employs polymerase chain reaction (PCR) technology to swiftly and precisely pinpoint the presence of Candida species in clinical samples. For example, in May 2024, Bosch Healthcare Solutions GmbH, a Germany-based medical technology producer, introduced a PCR test for Candida auris detection on the Vivalytic platform, offering entirely automated, quick testing within an hour at the point of care. This sophisticated test permits prompt screenings and notably differs from traditional culture methods, which demand one to three days in centralized labs, consequently delaying diagnosis and treatment. Crafted for clinical environments, the test is especially advantageous for high-risk patients, facilitating timely diagnosis and therapeutic action to counter the significant health risks tied to C. auris infections.
Who Are The Companies Competing Within The Candida Infection Testing Market?
Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC
Get The Full Candida Infection Testing Market Report:
https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report
Which Region Accounts For The Largest Portion Of The Candida Infection Testing Market?
North America was the largest region in the candida infection testing market in 2025. The regions covered in the candida infection testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Candida Infection Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report
Browse Through More Reports Similar to the Global Candida Infection Testing Market 2026, By The Business Research Company
Pseudomonas Aeruginosa Infection Treatment Market Report 2026
High Level Disinfection Services Market Report 2026
Uv Disinfection Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/uv-disinfection-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
